# Enzymatic therapy for celiac

Contract manufacturing (CMO/CDMO/toll) — Engineered enzymes and inhibitors of target enzymes are moving toward pharmaceutical protection against gluten exposure in celiac disease.

Source: https://en.bioecon.ru/market/contract-manufacturing/enzymatic-therapy-celiac/